These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 10565747)
1. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen. Lechevallier E; Eghazarian C; Ortega JC; Roux F; Coulange C Urology; 1999 Nov; 54(5):857-61. PubMed ID: 10565747 [TBL] [Abstract][Full Text] [Related]
2. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560 [TBL] [Abstract][Full Text] [Related]
3. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Richie JP; Catalona WJ; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; deKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC Urology; 1993 Oct; 42(4):365-74. PubMed ID: 7692657 [TBL] [Abstract][Full Text] [Related]
4. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Bangma CH; Kranse R; Blijenberg BG; Schröder FH Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415 [TBL] [Abstract][Full Text] [Related]
5. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml. Morote J; Trilla E; Esquena S; Serrallach F; Abascal JM; Muñoz A; Id M'Hammed Y; de Torres IM Eur Urol; 2002 Oct; 42(4):333-7. PubMed ID: 12361897 [TBL] [Abstract][Full Text] [Related]
6. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice. Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL. Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430 [TBL] [Abstract][Full Text] [Related]
9. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma. Thakur V; Singh PP; Talwar M; Mukherjee U Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330 [TBL] [Abstract][Full Text] [Related]
10. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249 [TBL] [Abstract][Full Text] [Related]
11. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml. Okihara K; Fritsche HA; Ayala A; Johnston DA; Allard WJ; Babaian RJ J Urol; 2001 Jun; 165(6 Pt 1):1930-6. PubMed ID: 11371884 [TBL] [Abstract][Full Text] [Related]
12. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model. Catalona WJ; Partin AW; Finlay JA; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL Urology; 1999 Aug; 54(2):220-4. PubMed ID: 10443714 [TBL] [Abstract][Full Text] [Related]
13. Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics. Guthman DA; Wilson TM; Blute ML; Bergstralh EJ; Zincke H; Oesterling JE Urology; 1993 Aug; 42(2):150-4. PubMed ID: 7690170 [TBL] [Abstract][Full Text] [Related]
14. Short-term effect of digital rectal examination on serum prostate-specific antigen levels. A prospective study. Cevik I; Türkeri LN; Ozveri H; Ilker Y; Akdaş A Eur Urol; 1996; 29(4):403-6. PubMed ID: 8791045 [TBL] [Abstract][Full Text] [Related]
15. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Finne P; Finne R; Auvinen A; Juusela H; Aro J; Määttänen L; Hakama M; Rannikko S; Tammela TL; Stenman U Urology; 2000 Sep; 56(3):418-22. PubMed ID: 10962306 [TBL] [Abstract][Full Text] [Related]
16. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients. Dell'Atti L J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458 [TBL] [Abstract][Full Text] [Related]
17. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium. Arch Intern Med; 1995 Feb; 155(4):389-92. PubMed ID: 7531426 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069 [TBL] [Abstract][Full Text] [Related]
19. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men. Bangma CH; Kranse R; Blijenberg BG; Schröder FH Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414 [TBL] [Abstract][Full Text] [Related]
20. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination. Morote J; Raventós CX; Lorente JA; Enbabo G; López M; de Torres I Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]